🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jefferies Group’s REPL Holdings & Trades

First Buy
Q1 2024
Duration Held
5 Quarters
Largest Add
Q1 2024
+1 M Shares
Current Position
714,225 Shares
$5.46 M Value

Jefferies Group's REPL Position Overview

Jefferies Group (via Jefferies Financial Group Inc.) currently holds 714,225 shares of Replimune Group, Inc. (REPL) worth $5.46 M, representing 0.04% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 5 quarters.

Based on 13F filings, Jefferies Group has maintained this position in REPL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 714,226 shares. Largest reduction occurred in Q3 2024, reducing 1 M shares.

Analysis based on 13F filings available since 2013 Q2

Jefferies Group's Replimune Group (REPL) Holding Value Over Time

Track share changes against reported price movement

Quarterly Replimune Group (REPL) Trades by Jefferies Group

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 -1 Reduce 0.00% 714,225 $7.65
Q4 2025 +714,226 New Buy 714,226 $9.72
Q3 2024 -1 M Sold Out 0 $0.00
Q1 2024 +1 M New Buy 1 M $8.17

Jefferies Group's Replimune Group Investment FAQs

Jefferies Group first purchased Replimune Group, Inc. (REPL) in Q1 2024, acquiring 1,000,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jefferies Group has held Replimune Group, Inc. (REPL) for 5 quarters since Q1 2024.

Jefferies Group's largest addition to Replimune Group, Inc. (REPL) was in Q1 2024, adding 1,000,000 shares worth $8.17 M.

According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 714,225 shares of Replimune Group, Inc. (REPL), valued at approximately $5.46 M.

As of the Q1 2026 filing, Replimune Group, Inc. (REPL) represents approximately 0.04% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.

Jefferies Group's peak holding in Replimune Group, Inc. (REPL) was 1,000,000 shares, as reported at the end of Q1 2024.